Skip to main content

Peer Review reports

From: Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology

Original Submission
2 Aug 2018 Submitted Original manuscript
3 Sep 2018 Reviewed Reviewer Report - Vincent Kam Wai Wong
19 Sep 2018 Reviewed Reviewer Report - Yan Li
25 Sep 2018 Author responded Author comments - Zhitong Bing
Resubmission - Version 2
25 Sep 2018 Submitted Manuscript version 2
5 Oct 2018 Author responded Author comments - Zhitong Bing
Resubmission - Version 3
5 Oct 2018 Submitted Manuscript version 3
Publishing
9 Oct 2018 Editorially accepted
6 Nov 2018 Article published 10.1186/s12906-018-2347-x

You can find further information about peer review here.

Back to article page